Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine added to ropivacaine for interscalene block in rotator cuff repair
IRCT20181011041308N4Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jan 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexmedetomidine and ropivacaine in rotator cuff tear (2 arms), sponsored by Iran University of Medical Sciences. Started Jan 2022; status: completed.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on IRCT20181011041308N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181011041308N4.